Literature DB >> 26474110

Inotropic Effects of Experimental Hyperthermia and Hypothermia on Left Ventricular Function in Pigs-Comparison With Dobutamine.

Alessio Alogna1, Martin Manninger, Michael Schwarzl, Birgit Zirngast, Paul Steendijk, Jochen Verderber, David Zweiker, Heinrich Maechler, Burkert M Pieske, Heiner Post.   

Abstract

OBJECTIVES: The results from the recent Targeted Temperature Management trial raised the question whether cooling or merely the avoidance of fever mediates better neurologic outcome in resuscitated patients. As temperature per se is a major determinant of cardiac function, we characterized the effects of hyperthermia (40.5°C), normothermia (38.0°C), and mild hypothermia (33.0°C) on left ventricular contractile function in healthy pigs and compared them with dobutamine infusion.
DESIGN: Animal study.
SETTING: Large animal facility, Medical University of Graz, Graz, Austria.
SUBJECTS: Nine anesthetized and mechanically ventilated closed-chest Landrace pigs (67 ± 2 kg).
INTERVENTIONS: Core body temperature was controlled using an intravascular device. At each temperature step, IV dobutamine was titrated to double maximum left ventricular dP/dt (1.8 ± 0.1 µg/kg/min at normothermia). Left ventricular pressure-volume relationships were assessed during short aortic occlusions. Left ventricular contractility was assessed by the calculated left ventricular end-systolic volume at an end-systolic left ventricular pressure of 100 mm Hg.
MEASUREMENTS AND MAIN RESULTS: Heart rate (98 ± 4 vs 89 ± 4 vs 65 ± 2 beats/min; all p < 0.05) and cardiac output (6.7 ± 0.3 vs 6.1 ± 0.3 vs 4.4 ± 0.2 L/min) decreased with cooling from hyperthermia to normothermia and mild hypothermia, whereas left ventricular contractility increased (left ventricular end-systolic volume at a pressure of 100 mm Hg: 74 ± 5 mL at hyperthermia, 52 ± 4 mL at normothermia, and 41 ± 3 mL at mild hypothermia; all p < 0.05). The effect of cooling on left ventricular end-systolic volume at a pressure of 100 mm Hg (hyperthermia to normothermia: -28% ± 3% and normothermia to mild hypothermia: -20% ± 5%) was of comparable effect size as dobutamine at a given temperature (hyperthermia: -28% ± 4%, normothermia: -27% ± 6%, and mild hypothermia: -27% ± 9%).
CONCLUSIONS: Cooling from hyperthermia to normothermia and from normothermia to mild hypothermia increased left ventricular contractility to a similar degree as a significant dose of dobutamine in the normal porcine heart. These data indicate that cooling can reduce the need for positive inotropes and that lower rather than higher temperatures are appropriate for the resuscitated failing heart.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26474110     DOI: 10.1097/CCM.0000000000001358

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  9 in total

1.  Cortical Bone Stem Cell Therapy Preserves Cardiac Structure and Function After Myocardial Infarction.

Authors:  Thomas E Sharp; Giana J Schena; Alexander R Hobby; Timothy Starosta; Remus M Berretta; Markus Wallner; Giulia Borghetti; Polina Gross; Daohai Yu; Jaslyn Johnson; Eric Feldsott; Danielle M Trappanese; Amir Toib; Joseph E Rabinowitz; Jon C George; Hajime Kubo; Sadia Mohsin; Steven R Houser
Journal:  Circ Res       Date:  2017-09-14       Impact factor: 17.367

2.  Effects of mechanical ventilation versus apnea on bi-ventricular pressure-volume loop recording.

Authors:  M Dam Lyhne; C Schmidt Mortensen; J Valentin Hansen; S Juel Dragsbaek; J E Nielsen-Kudsk; A Andersen
Journal:  Physiol Res       Date:  2022-01-19       Impact factor: 1.881

3.  Mild Hypothermia May Offer Some Improvement to Patients with MODS after CPB Surgery.

Authors:  Xiaoqi Zhao; Tianxiang Gu; Zongyi Xiu; Enyi Shi; Lei Yu
Journal:  Braz J Cardiovasc Surg       Date:  2016 May-Jun

4.  Acute hyperglycaemia is not associated with the development of atrial fibrillation in healthy pigs.

Authors:  Martin Manninger; David Zweiker; Martin Dobrovnik; Arne van Hunnik; Ursula Rohrer; Birgit Zirngast; Viktoria Herbst; Heinrich Maechler; Ulrich Schotten; Andreas Zirlik; Daniel Scherr
Journal:  Sci Rep       Date:  2020-07-17       Impact factor: 4.379

5.  Protein Kinase C Inhibition With Ruboxistaurin Increases Contractility and Reduces Heart Size in a Swine Model of Heart Failure With Reduced Ejection Fraction.

Authors:  Thomas E Sharp; Hajime Kubo; Remus M Berretta; Timothy Starosta; Markus Wallner; Giana J Schena; Alexander R Hobby; Daohai Yu; Danielle M Trappanese; Jon C George; Jeffery D Molkentin; Steven R Houser
Journal:  JACC Basic Transl Sci       Date:  2017-12-25

6.  Cardiac power output accurately reflects external cardiac work over a wide range of inotropic states in pigs.

Authors:  Dawud Abawi; Alessandro Faragli; Michael Schwarzl; Martin Manninger; David Zweiker; Karl-Patrik Kresoja; Jochen Verderber; Birgit Zirngast; Heinrich Maechler; Paul Steendijk; Burkert Pieske; Heiner Post; Alessio Alogna
Journal:  BMC Cardiovasc Disord       Date:  2019-10-15       Impact factor: 2.298

7.  Cardiovascular magnetic resonance-derived left ventricular mechanics-strain, cardiac power and end-systolic elastance under various inotropic states in swine.

Authors:  A Faragli; R Tanacli; C Kolp; D Abawi; T Lapinskas; C Stehning; B Schnackenburg; F P Lo Muzio; L Fassina; B Pieske; E Nagel; H Post; S Kelle; A Alogna
Journal:  J Cardiovasc Magn Reson       Date:  2020-11-30       Impact factor: 5.364

Review 8.  Physiological Changes in Subjects Exposed to Accidental Hypothermia: An Update.

Authors:  Lars J Bjertnæs; Torvind O Næsheim; Eirik Reierth; Evgeny V Suborov; Mikhail Y Kirov; Konstantin M Lebedinskii; Torkjel Tveita
Journal:  Front Med (Lausanne)       Date:  2022-02-23

9.  Impact of Increasing Lower Body Negative Pressure and Its Abrupt Release on Left Ventricular Hemodynamics in Anesthetized Pigs.

Authors:  Birgit Zirngast; Leonhard Berboth; Martin Manninger; Helmut Hinghofer-Szalkay; Daniel Scherr; Lonnie G Petersen; Nandu Goswami; Alessio Alogna; Heinrich Maechler
Journal:  J Clin Med       Date:  2022-10-03       Impact factor: 4.964

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.